Sponsor:
Dartmouth-Hitchcock Medical Center
Code:
NCT07043270
Conditions
Pancreas Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nab-paclitaxel + Gemcitabine
modified FOLFIRINOX (mFOLFIRINOX)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-27. This information was provided to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center on 2025-10-20.